BioMarin Pharmaceutical
BioMarin Pharmaceutical is a global biotechnology company specializing in the development and commercialization of innovative therapies for rare genetic diseases. With a strong focus on research and development, BioMarin leverages advanced science to address unmet medical needs in the biopharmaceutical sector. The company’s portfolio includes treatments for conditions such as phenylketonuria (PKU), mucopolysaccharidosis, and other rare disorders. Committed to improving patient outcomes, BioMarin collaborates with healthcare professionals and patient communities worldwide. Through its dedication to scientific excellence and patient-centric solutions, BioMarin Pharmaceutical continues to advance breakthroughs in biotechnology, delivering hope and improved quality of life for individuals affected by rare diseases.
